Showing results (1011-1020 of 1,525) with videos related to
Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|March 10, 2023
Tiered approach to evaluate the CYP3A victim and perpetrator drug-drug interaction potential for vonoprazan using PBPK modeling and clinical data to inform labelingDarcy J Mulford, Diane Ramsden, Liming Zhang, et al.CPT: Pharmacometrics & Systems Pharmacology|March 10, 2023
PK/PD modeling to characterize placebo and treatment effect of omalizumab for chronic spontaneous urticariaElise Oh, Russ Wada, Kha Le, et al.CPT: Pharmacometrics & Systems Pharmacology|March 27, 2023
Prediction of gastric pH-mediated drug exposure using physiologically-based pharmacokinetic modeling: A case study of itraconazoleEunsol Yang, Kyung-Sang Yu, SeungHwan LeeCPT: Pharmacometrics & Systems Pharmacology|February 25, 2023
PBPK modeling of ivermectin-Considerations for the purpose of developing alternative routes to optimize its safety profileKaren Rowland Yeo, David WescheCPT: Pharmacometrics & Systems Pharmacology|February 25, 2023
Genetic and non-genetic factors influencing efavirenz population pharmacokinetics among human immunodeficiency virus-1-infected children in EthiopiaAdugna Chala, Eliford Ngaimisi Kitabi, Jemal Hussien Ahmed, et al.CPT: Pharmacometrics & Systems Pharmacology|March 1, 2023
Physiologically based pharmacokinetic modeling for development and applications of a virtual celiac disease population using felodipine as a model drugFarzaneh Salem, Ali Nimavardi, Jennypher Mudunuru, et al.CPT: Pharmacometrics & Systems Pharmacology|February 8, 2023
Investigation of simplified physiologically-based pharmacokinetic models in rat and humanEstelle Yau, Andrés Olivares-Morales, Kayode Ogungbenro, et al.CPT: Pharmacometrics & Systems Pharmacology|August 2, 2016
Levofloxacin-Induced QTc Prolongation Depends on the Time of Drug AdministrationL Kervezee, V Gotta, J Stevens, et al.CPT: Pharmacometrics & Systems Pharmacology|July 21, 2016
Population Exposure-Response Modeling of Naloxegol in Patients With Noncancer-Related Pain and Opioid-Induced ConstipationN Al-Huniti, J C Nielsen, M M Hutmacher, et al.CPT: Pharmacometrics & Systems Pharmacology|August 3, 2016
Modeling Variability in the Progression of Huntington's Disease A Novel Modeling Approach Applied to Structural Imaging Markers from TRACK-HDJ H Warner, C SampaioPageof 153